lecanemab

November 29, 2022

Alzheimer’s drug may benefit some patients, new data shows

[ad_1] The drug lecanemab, made by Eisai and Biogen, also carries a risk of brain swelling and bleeding and should be investigated further, a report of the findings said. [ad_2] Source link
Alzheimer’s drug may benefit some patients, new data shows
This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
Read more